The global market for transport protein assay kits is anticipated to grow at a CAGR of 12.3% from 2024 to 2032. To move molecules across the plasma membrane, transport proteins perform both active and passive transport functions. This is expected to boost the growth of the market for transport protein assay kits over the forecast period. The characteristics of Transport protein assay kits, such as their rapid diagnosis, cost-effectiveness, and user-friendliness, are anticipated to be one of the major factors driving the market's expansion over the forecast period.
Moreover, early analysis and drug delivery, among other functions, offer investors the opportunity to support the biotechnology and pharmaceutical industries financially. These factors are also driving the growth of the market for Transport protein assay kits. In addition, factors such as an increase in the number of healthcare responsiveness programs, a rise in the number of government recruits, and financial support for the accurate diagnosis of diseases are anticipated to drive market expansion in the coming years. In addition, the emerging applications of transport protein assay kits, as well as the rising demand for cost-effective clinical operations, are anticipated to drive market growth shortly. In addition, factors such as the presence of major market contributors across the globe, rising investment in the biotechnology and pharmaceutical sectors, and rising R&D and technology development activities are anticipated to boost the growth of the Transport protein assay kits market in the coming years.
North America Remains as the Global Leader
During the forecast period, the Transport protein assay kits market in North America accounted for the largest share in 2023, due to factors such as a rise in healthcare awareness, technological advancements, and an increase in research and development activities. On the other hand, the European market for Transport protein assays kits is anticipated to expand rapidly over the forecast period, owing to factors such as rising urbanization and healthcare expenditure increases. Other factors that influence the growth of the regional market include the increase in chronic diseases and the rise in government spending on R&D.
Market Competition to Intensify During the Forecast Period
Thermo Fisher Scientific Inc., Bio Vision Incorporated, Novus Biologicals, Inc., My BioSource, Merck KGaA, Solvo biotechnology, Abbkine, Inc., KAC CO.Ltd, Molecular Devices, LLC, and others are key contributors to the market for transport protein assay kits. Recent technological advancements, mergers and acquisitions, and company partnerships involving the development of Transport protein assay kits are anticipated to create lucrative growth opportunities for the market over the forecast period.
For example, in July 2021, Ludger introduced a 1-3,4 Fucosidase enzyme kit [Cat # LZ-FUCOSIDAS-01-KIT] with a specificity developed in collaboration with Quadram Institute of Biosciences (Norwich) for the Glycoenzymes for Bioindustries consortium initiative. This exoglycosidase kit contains 1-3,4 fucosidase enzyme (a recombinant protein derived from the intestinal symbiont Ruminococcusgnavus) as well as a reaction buffer. It is designed to process up to 50 samples (each containing 15 g of glycoprotein or 0.5 g of free glycan).
Beckman Coulter Life Sciences subsequently announced in February 2019 the launch of the Apostle MiniMaxTM High-Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company. The Apostle's industry-leading chemistry, in conjunction with Beckman Coulter Life Sciences' portfolio of genomic reagents and liquid handling platforms, enables researchers to meet the rising demand for sequencing of tumor-derived cfDNA, as cfDNA workflows expand beyond theoretical and into human health applications.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Transport Protein Assay Kits market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Product
| |
Applications
| |
End user
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
